Literature DB >> 20414050

IL-33 and IL-33 receptors in host defense and diseases.

Keisuke Oboki1, Tatsukuni Ohno, Naoki Kajiwara, Hirohisa Saito, Susumu Nakae.   

Abstract

Interleukin-33 (IL-33) is a member of the IL-1 cytokine family, which includes IL-1 and IL-18. IL-33 is considered to be crucial for induction of Th2-type cytokine-associated immune responses such as host defense against nematodes and allergic diseases by inducing production of such Th2-type cytokines as IL-5 and IL-13 by Th2 cells, mast cells, basophils and eosinophils. In addition, IL-33 is involved in the induction of non-Th2-type acute and chronic inflammation as a proinflammatory cytokine, similar to IL-1 and IL-18. In this review, we summarize and discuss the current knowledge regarding the roles of IL-33 and IL-33 receptors in host defense and disease development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20414050     DOI: 10.2332/allergolint.10-RAI-0186

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  68 in total

Review 1.  Research progress on interleukin-33 and its roles in the central nervous system.

Authors:  Ping Han; Wen-Li Mi; Yan-Qing Wang
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

Review 2.  Interleukin-33 biology with potential insights into human diseases.

Authors:  Gaby Palmer; Cem Gabay
Journal:  Nat Rev Rheumatol       Date:  2011-04-26       Impact factor: 20.543

Review 3.  State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve?

Authors:  Salvatore Chirumbolo
Journal:  Blood Transfus       Date:  2011-12-21       Impact factor: 3.443

4.  IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G.

Authors:  Emma Lefrançais; Stephane Roga; Violette Gautier; Anne Gonzalez-de-Peredo; Bernard Monsarrat; Jean-Philippe Girard; Corinne Cayrol
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

5.  Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy.

Authors:  Masashi Ikutani; Koichi Tsuneyama; Makoto Kawaguchi; Junya Fukuoka; Fujimi Kudo; Susumu Nakae; Makoto Arita; Yoshinori Nagai; Satoshi Takaki; Kiyoshi Takatsu
Journal:  JCI Insight       Date:  2017-04-06

Review 6.  New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?

Authors:  Margaret E Walker; Julianne K Hatfield; Melissa A Brown
Journal:  Biochim Biophys Acta       Date:  2011-02-25

7.  IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells.

Authors:  Xiao-Cui Liu; Xiao-Fei Liu; Cong-Xiang Jian; Chen-Jun Li; Shou-Zhi He
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

8.  Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria.

Authors:  E Ayimba; J Hegewald; A Y Ségbéna; R G Gantin; C J Lechner; A Agosssou; M Banla; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

9.  Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease.

Authors:  Suleyman Serdar Koca; Murat Kara; Firat Deniz; Metin Ozgen; Caner Feyzi Demir; Nevin Ilhan; Ahmet Isik
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

10.  The GOLD domain-containing protein TMED1 is involved in interleukin-33 signaling.

Authors:  Dympna J Connolly; Luke A J O'Neill; Anne F McGettrick
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.